<b>Genetically predicted mood disorders increased risk of Cisplatin-induced hearing loss in childhood cancer: Evidence from a Bidirectional Mendelian randomization study</b>

<i>It remains unclear whether the mood swings in children with cancer are causally related to the increased risk of hearing loss caused by cisplatin.</i><i>The first investigation into the interaction between mood swings and cisplatin-induced hearing loss.</i><i>It is a two-sample Mendelian randomization analysis. Mendelian randomization (MR) emerges as a valuable approach, employing genetic variations as instrumental variables to infer causal links between exposure factors and outcomes.</i>